Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Neuroscience and Biobehavioral Reviews
|
August 22, 2022
Effects of psychotropic drugs on ocular parameters relevant to traffic safety: A systematic review
Thomas R Arkell, Ashley Brooks-Russell, Luke A Downey, et al.
Journal of Cannabis Research
|
September 6, 2023
Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey
Thomas R Arkell, Sarah V Abelev, Llewellyn Mills, et al.
Addiction Biology
|
December 22, 2021
Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials
Thomas R Arkell, Richard C Kevin, Frederick Vinckenbosch, et al.
The British Journal of Dermatology
|
June 13, 2009
Attenuation of Flightless I, an actin-remodelling protein, improves burn injury repair via modulation of transforming growth factor (TGF)-beta1 and TGF-beta3
D H Adams, N Ruzehaji, X L Strudwick, et al.
Drug Testing and Analysis
|
August 24, 2019
Detection of Δ<sup>9</sup> THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point-of-collection testing devices
Thomas R Arkell, Richard C Kevin, Jordyn Stuart, et al.
Advances in Therapy
|
February 13, 2026
X-Linked Retinitis Pigmentosa (XLRP): An Investigation of the Impact of XLRP on Health-Related Quality of Life of Carers in Great Britain
Nicholas S Durno, Tom R Denee, Krystallia Pantiri, et al.
Harm Reduction Journal
|
May 28, 2024
Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22)
Llewellyn Mills, Jonathon C Arnold, Anastasia Suraev, et al.
Psychopharmacology
|
May 3, 2019
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
Thomas R Arkell, Nicholas Lintzeris, Richard C Kevin, et al.
Human Psychopharmacology
|
July 31, 2020
The effect of cannabidiol on simulated car driving performance: A randomised, double-blind, placebo-controlled, crossover, dose-ranging clinical trial protocol
Danielle McCartney, Melissa J Benson, Anastasia S Suraev, et al.
Journal of Sleep Research
|
October 20, 2020
The effect of daily aerobic cycling exercise on sleep quality during inpatient cannabis withdrawal: A randomised controlled trial
Danielle McCartney, Ashling D Isik, Kieron Rooney, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Neuroscience and Biobehavioral Reviews
|
August 22, 2022
Effects of psychotropic drugs on ocular parameters relevant to traffic safety: A systematic review
Thomas R Arkell, Ashley Brooks-Russell, Luke A Downey, et al.
Journal of Cannabis Research
|
September 6, 2023
Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey
Thomas R Arkell, Sarah V Abelev, Llewellyn Mills, et al.
Addiction Biology
|
December 22, 2021
Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials
Thomas R Arkell, Richard C Kevin, Frederick Vinckenbosch, et al.
The British Journal of Dermatology
|
June 13, 2009
Attenuation of Flightless I, an actin-remodelling protein, improves burn injury repair via modulation of transforming growth factor (TGF)-beta1 and TGF-beta3
D H Adams, N Ruzehaji, X L Strudwick, et al.
Drug Testing and Analysis
|
August 24, 2019
Detection of Δ<sup>9</sup> THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point-of-collection testing devices
Thomas R Arkell, Richard C Kevin, Jordyn Stuart, et al.
Advances in Therapy
|
February 13, 2026
X-Linked Retinitis Pigmentosa (XLRP): An Investigation of the Impact of XLRP on Health-Related Quality of Life of Carers in Great Britain
Nicholas S Durno, Tom R Denee, Krystallia Pantiri, et al.
Harm Reduction Journal
|
May 28, 2024
Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22)
Llewellyn Mills, Jonathon C Arnold, Anastasia Suraev, et al.
Psychopharmacology
|
May 3, 2019
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
Thomas R Arkell, Nicholas Lintzeris, Richard C Kevin, et al.
Human Psychopharmacology
|
July 31, 2020
The effect of cannabidiol on simulated car driving performance: A randomised, double-blind, placebo-controlled, crossover, dose-ranging clinical trial protocol
Danielle McCartney, Melissa J Benson, Anastasia S Suraev, et al.
Journal of Sleep Research
|
October 20, 2020
The effect of daily aerobic cycling exercise on sleep quality during inpatient cannabis withdrawal: A randomised controlled trial
Danielle McCartney, Ashling D Isik, Kieron Rooney, et al.
Page
of 4